XDH and gout: The oxidative form of XOR, now indicated as XO, is involved in multiple enzymatic activities, including the metabolism of purines, and its inhibition represents the mainstay therapy of gout, a disease characterized by the accumulation of uric acid (UA), the end-stage product of purine metabolism.7